Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Taking ‘shots on goal’: The continuing fight to bring precision medicine to rheumatology Rob Volansky
-
- Precision medicine in rheumatoid arthritis: Hype or hope? Stanley Cohen, MD
- Amgen clear to acquire Horizon after agreement with Federal Trade Commission Erich Martin
- ‘Bubbling with new ideas’: Tocilizumab, steroids and the future of GCA treatment Rob Volansky
- Celebrating the life of Frederick Wolfe, MD: ‘The consummate physician-scientist’ Erich Martin
- Disentangling long COVID from fibromyalgia: Patients often feel ‘disrespected, ignored’ Rob Volansky
- EULAR definition of difficult-to-treat rheumatoid arthritis leaves ‘some holes’ Erich Martin
- FDA approves Ilaris for the treatment of gout flares in adults Erich Martin
- Gout clinical practice guidelines disagree on when to start urate lowering therapy Erich Martin
-
- Head-to-head trial data in rheumatoid arthritis scant, offer ‘shaky evidence’ Rob Volansky
- Multiple recent FDA approvals in pediatric rheumatology overcome ‘delayed’ trials Rob Volansky
- New ACR SSc-ILD guidelines warn against glucocorticoids as first-line therapy Erich Martin
- New-onset inflammatory diseases ‘may be triggered’ by COVID-19 infection, vaccination Erich Martin
- Nintedanib slows loss of lung function in limited cutaneous systemic sclerosis, ILD Erich Martin
- Patients receiving TNFi for rheumatoid arthritis more likely to develop psoriasis Erich Martin
- Patients with COVID-19 have 43% increased risk for new-onset autoimmune diseases Erich Martin
- Patients with worse osteoarthritis pain, physical function benefit most from exercise Erich Martin
-